You have 9 free searches left this month | for more free features.

repaglinide

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Tempe (Repaglinide, Selpercatinib)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Jul 20, 2022

Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

Completed
  • Malaria
  • Belfast, Northern Ireland, United Kingdom
    Novartis Investigative Site
Nov 2, 2022

Healthy Trial in Dallas (LY3871801, Methotrexate, Warfarin)

Recruiting
  • Healthy
  • Dallas, Texas
    Covance Dallas
Dec 26, 2022

Healthy Trial in Neu-Ulm (ATR-002, Placebo, Repaglinide)

Recruiting
  • Healthy
  • Neu-Ulm, Germany
    Atriva study site
Sep 22, 2022

Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)

Not yet recruiting
  • Healthy Participants
  • Salt Lake City, Utah
    ICON Phase 1 Clinic
Oct 16, 2023

Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)

Recruiting
  • Sickle Cell Disease
  • San Antonio, Texas
    ICON Early Phase Services, LLC
Jul 31, 2023

Healthy Trial in Cypress, South Miami, San Antonio (Imlunestrant, Repaglinide, Omeprazole)

Completed
  • Healthy
  • Cypress, California
  • +2 more
Nov 23, 2022

GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)

Recruiting
  • GIST - Gastrointestinal Stromal Tumor
  • Jacksonville, Florida
  • +2 more
Mar 7, 2022

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)

Completed
  • Mitochondrial Disease
  • Leeds, United Kingdom
    Volunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021

Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)

Completed
  • Diabetes Mellitus, Type 2
  • Leicester, Leicestershire, United Kingdom
  • +1 more
Jan 29, 2020

Drug-drug Interaction Trial in Daytona Beach, Dallas (tucatinib, itraconazole, rifampin)

Completed
  • Drug-drug Interaction
  • Daytona Beach, Florida
  • +1 more
Dec 16, 2019

Diabetes Trial in Palermo (Dulaglutide, Aspart insulin, Glargine)

Completed
  • Diabetes Mellitus
  • Palermo, Italy
    Internal Medicine Ward, University of Palermo
Jan 29, 2019

Diabetes, Diabetes, Type 2 Trial in Beijing, Shanghai (repaglinide, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Beijing, Beijing, China
  • +2 more
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Houston (repaglinide, glyburide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Houston, Texas
    Novo Nordisk Investigational Site
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Miami, Tacoma (repaglinide, metformin, repaglinide and metformin combination tablet)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Miami, Florida
  • +1 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Austin (repaglinide, metformin, repaglinide and metformin combination tablet)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Austin, Texas
    Novo Nordisk Investigational Site
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Padova (repaglinide, glyburide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Padova, Italy
    Novo Nordisk Investigational Site
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Shanghai, Chengdu, Beijing (repaglinide, Glurenorm®, Glucobay®)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Shanghai, Shanghai, China
  • +3 more
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Athens (repaglinide, biphasic human insulin 30, insulin NPH)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Athens, Greece
    Novo Nordisk Investigational Site
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in China (repaglinide, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Fuzhou, Fujian, China
  • +16 more
Dec 19, 2016

Diabetes, Diabetes, Type 2 Trial in Beijing, Shanghai (repaglinide, isophane human insulin, insulin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • +2 more
  • Beijing, Beijing, China
  • +2 more
Feb 17, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (repaglinide, insulin NPH)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide
  • insulin NPH
  • Shatin, New Territories, Hong Kong
  • +11 more
Feb 17, 2017

Cystic Fibrosis Related Diabetes, Pancreatic Insufficiency Trial in Saint Louis (, repaglinide)

Completed
  • Cystic Fibrosis Related Diabetes
  • Pancreatic Insufficiency
  • placebo
  • repaglinide
  • Saint Louis, Missouri
    Washington University School of Medicine
May 3, 2017